Overview

Montelukast Back to School Asthma Study (0476-340)

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study, in children with chronic asthma, evaluates the number of days of worsening asthma during 8 weeks of treatment with montelukast after treatment is started for the first day of school.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast